Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)
Clinical trial NCT04084769 · COMPLETED
Trial details
- NCT number
- NCT04084769
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-03
- Primary completion
- 2020-09-14
- Enrollment
- 570
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.